Blood Bank Instructions

Size: px
Start display at page:

Download "Blood Bank Instructions"

Transcription

1 Blood Bank Instructions Blood Bank Transfusion Services Available at MidMichigan Laboratories-Clare, MidMichigan Laboratories-Gladwin, MidMichigan Laboratories-Gratiot, and MidMichigan Laboratories-Midland Components/Services Available Component Clare Gladwin Gratiot Midland Notes Red cells N/A N/A N/A N/A All affiliates leuko-reduced Leuko-reduced red cells X X X X Whole blood N/A N/A N/A N/A Fresh frozen plasma X X X X 30 minutes thawing time Cryoprecipitate Supplier X X X 30 minutes thawing time Leukocytes Supplier Supplier Supplier Supplier Platelets, random Supplier Supplier Supplier Supplier 2 to 4 hours for delivery Platelets, pheresis Supplier Supplier Supplier Supplier 2 to 4 hours for delivery Autologous Ernie Supplier Supplier Supplier donation Wallace By appointment Directed Red cells Supplier Supplier Supplier Supplier Requires physician request RhoGAM Available at Wackerly Laboratory, POB Laboratory, and Mount X Pharmacy X X Pleasant Health Park Monday through Friday 8 a.m. to 4 p.m. Therapeutic phlebotomy Nursing Nursing Nursing Therapeutic apheresis Infusion Center Davita Davita Davita By appointment By appointment Michigan Blood is the Supplier for Clare, Gladwin, Gratiot and Midland. Michigan Blood is located in Saginaw.

2 Ordering Components You may order components using a variety of methods: You can place an order in Hospital Information System (HIS). This order is electronically sent to the Blood Bank where it will be processed. Once processed, it is placed on a collection list to be drawn according to priority. You can place an order into LIS (Laboratory Information System). This order is automatically routed to a collection list. You can send a laboratory downtime request to laboratory. Laboratory staff will place order into LIS where it will be routed to a collection list. Release of Components from Blood Bank When Nursing Unit is ready for component to be issued, they should initiate process by calling laboratory to inform them that a request is forthcoming. Nursing station must then send (or bring) to the Blood Bank an addressographed or handprinted request containing: Patient name Medical record number Amount and type of component requested Current patient location In Clare, Gladwin and Gratiot nursing unit staff present to the blood bank for unit release. In Midland units will be sent via pneumatic tube. If tube system is not available, the Nursing Unit must request that Transportation Department come to Blood Bank with appropriate request form for desired components. Administration of Blood and Blood Components When blood arrives at nursing station, identify recipient and donor unit: Accurate identification of donor s blood and intended recipient may be the single most important step in ensuring transfusion safety. Most fatal hemolytic transfusion reactions occur because ABO-incompatible RBCs were inadvertently administered. Plasma, platelets, and blood derivatives are also capable of causing serious transfusion reactions. Only a physician may order blood or blood products. Before sending for ordered blood, physician or nurse must start an intravenous (IV) with a Y-type or straight infusion set with filter. These sets are available in Supply/Distribution and should be stocked on all floors. Y-type administration set is used for alternating administration of blood and compatible intravenous solution, not for their simultaneous administration. When using Y-type set, 1 container must be shut off at all times. Except for patients who are fluid restricted, 50 ml to 100 ml of 0.9% saline solution can be transferred directly into a red blood cell container to decrease viscosity and increase flow rate. NO OTHER DILUENT IS ALLOWED. When multiple units are administered serially, IV administration set must be replaced by a new sterile set every 24 hours or after 6 units of blood have been filtered. Not all IV solutions are suitable for use with blood in a Y-type administration set, since some of those commonly used are not compatible with blood. Isotonic saline (0.9% solution) is completely compatible with blood. Recent work has shown that 5% dextrose in 0.25% saline will cause agglutination of red cells. Five percent dextrose in water will hemolyzed blood and must never be used. IV solutions containing calcium, such as lactated Ringer s, are prohibited because they can cause clotting on mixing with blood. All drugs, anesthetic agents, muscle relaxants, or vitamins may injure red cells and must never be added to blood. Blood Bank personnel will notify Nursing Unit by phone when ordered blood is ready. In Midland, units of blood may be transported via the pneumatic tube or by nursing staff at Clare, Gladwin and Gratiot. Only 1 unit of blood will ordinarily be issued at 1 time for any patient, unless more than 1 IV infusion has been started on that patient. (This does not apply to RhIG, platelets, or cryo.) Please notify Blood Bank if more than 1 unit of blood is needed at a time to avoid unnecessary delays. Only nursing personnel or physicians may accept blood or blood components on patient unit. When blood arrives on the floor, record the time of receipt on the unit tie tag. Document that the component is for intended recipient. Blood must not be stored in patient unit refrigerators, since a constant required temperature of 1 C to 6 C is not maintained. These refrigerators are not monitored. If unit of blood cannot be infused shortly after being received from Blood Bank, nurse should not accept delivery. An unused unit of blood MUST be returned to Blood Bank within 30 minutes of issue or it must be discarded. The cost of a wasted unit may be charged to Nursing Unit. If a unit is returned after a 30-minute time limit, we will hold that unit for up to 4 hours for

3 original recipient only. We can reissue unit to original recipient providing that transfusion of unit can be completed within 4 hours of original issue time. We cannot issue this unit to another recipient. Before infusion of any blood component, identity of intended recipient and intended infusion product(s) must be verified. Patient information (name, medical record #) found on the: Unit tag attached to blood product and patient armband must match exactly. Patient Armband: This identification should also include unit numbers of the blood product(s), which are found on the unit-tag and on unit container. Two nurses, 2 doctors, or a combination thereof should perform identification, except for RhoGAM. In the absence of 2 doctors or 2 nurses, 1 doctor or 1 nurse should perform identification with another available staff member. The persons performing identification must sign unit-tag. This identification must be performed at the patient s bedside. Unit-tag must remain attached to the component until end of transfusions. If any discrepancy is detected, return blood product and all Blood Bank slips to Blood Bank immediately for resolution. Before transfusion, unit of blood should be thoroughly mixed by gentle inversion. Each unit of blood has printed instructions for administration on label. Patient s blood pressure, pulse, temperature, and blood unit number should be recorded in nursing notes, as well as on unit-tag just prior to transfusion. Recording of vital signs provides a necessary baseline for later observations. When blood is released for emergency transfusions under unusual circumstances, a special notation will be attached directly to blood unit (BLOOD WARNING TAG). This information should suggest to physicians and nurses that particular caution must be exercised during transfusion, and that infusion should be terminated at first sign of any untoward reaction. If the persons starting transfusion have any questions about significance of this information, they should contact the Blood Bank before transfusion of blood. Routine crossmatch procedures will be completed ASAP. The following are examples of situations when a special warning is used: A patient presents a problem in typing and/or screening, but problem has not been thoroughly investigated by Blood Bank personnel due to immediate need for blood. Least reactive or crossmatch compatible blood is issued. A patient has autoimmune hemolytic anemia so that compatible blood is not available. Rhgenotype specific blood is issued. Please remove warning tag prior to infusion. Warning tag is for transfusionist s information. During Transfusion: The first 50-mL of blood should be infused slowly at 50 drops/minute as a test for an acute untoward reaction. Patient s vital signs should be checked again at 15 minutes. Most serious transfusion reactions will be apparent by this time. If patient s condition remains satisfactory, flow rate may be increased to 60 to 80 drops/ minute. Patient should be monitored periodically for remainder of transfusion. Transfusion should be completed in no more than 4 hours, 2 hours or less is preferred. If physician has indicated a transfusion time in excess of 4 hours, Blood Bank personnel can split unit and issue a small portion of unit while keeping the rest under monitored refrigeration for later infusion. Recommended transfusion times for blood and components are as follows: Component Red cells ( ml) Platelets, random: platelets, pheresis ( ml) Fresh frozen plasma ( ml) Cryoprecipitate (20 ml) (normal dose 6-12 units, ml) Recommended Infusion Time 2 hours best, but not to exceed 4 hours 30 minutes for pool of 6 random platelets or a single pheresis platelet 20 min/unit 20 to 30 minutes for standard dose Any transfusion that stops or slows appreciably during administration should be investigated. This is especially critical when a blood warmer is being used. Prolonged transfusion time also increases the chance of bacterial contamination in the blood unit. Signs and symptoms of a transfusion reaction follow in this chapter. At the Termination of the Transfusion: Record vital signs on unit-tag. Transfusionist must record presence or absence of a reaction on unit-tag. Original copy of unit-tag is to be retained for patient s chart. Empty blood bag should be disposed of on floor, except in cases of suspected transfusion reaction, in which case

4 blood bag and IV tubing should be sent to Blood Bank. Completed department copy of unit tie-tag should be returned to Blood Bank for all transfusions. Experienced personnel should observe patient who has received a transfusion for several hours. In case of a reaction, a properly completed Transfusion Reaction Investigation Record form must be filed in the Blood Bank before laboratory investigation is started. Unit number(s) of component(s) associated with reaction should be entered on this form. Intravenous solution, such as isotonic saline, used to start blood transfusion should be continued only if specifically ordered after blood or blood product is completely administered. Transfusion Reactions This manual is not intended to be a complete examination of all aspects of transfusion problems. It is designed to be used as a helpful guide for doctors and nurses when transfusion complications do occur. Transfusion reactions are as individual as the patients they affect. Descriptions of reactions may hold true only in part for a particular patient or may be masked by the patient s own disease process or medications taken prior to infusion. This manual should be kept handy at all nursing stations for quick reference. Transfusion reactions may be defined as any unfavorable event occurring in a patient during or following transfusion of blood or blood products. Since compatibility testing is performed for detection of antibodies to red cell antigens, adverse effects of transfusion are most commonly caused by other elements of blood, ie, leukocytes, platelets, plasma proteins, and infectious agents that may be present in blood products. In addition, every transfusion carries risk of development of red cell antibodies and transmission of disease. Transfusion complications fall into 2 major groups: Immediate reactions, seen within 48 hours of administration Delayed reactions and transmission of disease Whenever a reaction is suspected: Recheck identity and identification numbers of patient and component. Stop (but do not disconnect) infusion. Restart saline flow to keep open. Call patient s physician. Notify Blood Bank. Patient s physician or a staff physician should examine patient to establish severity of reaction. In certain minor reactions, blood may be cautiously restarted after patient has been treated with antihistamine. If situation warrants, nursing staff must initiate a Transfusion Reaction Investigation Record form, signed by attending physician, for swift and accurate investigation of these complications. In addition, a fresh urine specimen should be collected from patient and sent to laboratory ASAP. The Laboratory will come draw blood on patient if additional testing is needed. Immediate Effects Hemolytic Reactions: These reactions are usually due to clerical errors, misidentification of patient and/or donor unit, or direct abuse of blood product. Antigen-antibody interactions may also cause true hemolytic reactions. Red cell destruction may be intravascular, where red cells are hemolyzed directly in blood stream. Extravascular hemolysis, where red cells are removed by the reticuloendothelial system after reacting with an antibody, can lead to hyperbilirubinemia, with little or no release of hemoglobin into plasma. Clinical signs signaling hemolytic transfusion reaction will vary according to type of red cell destruction involved. Intravascular hemolysis is accompanied by immediate clinical signs associated with substances released by action of certain blood proteins (histamine, hemoglobin). There may be: Feeling of heat along vein into which blood is being infused Flushing of face Pain in the chest, lumbar region, or severe headache Nausea and vomiting Fever and chills Shock Signs associated with extravascular hemolysis may not be so dramatic, including only chills and fever several hours after infusion has ended. In an anesthetized patient, the only signs of a reaction may be an unexplained increase in pulse or increased bleeding. Hemoglobinemia and hemoglobinuria may occur, and severely affected patients may have complete renal shut down. Acute hemorrhagic diathesis can often be the outcome of a hemolytic reaction; it may be the ONLY sign of such a reaction if patient is anesthetized. Hemolysis may also initiate disseminated intravascular coagulopathy with consumption of

5 coagulation factors and fibrinolysis. Hemolytic events due to non-immunologic causes are not uncommon. Non-immune hemolysis may be due to overheating or freezing of infused blood, exposure to extreme osmotic stress, or to trauma and rarely causes life-threatening complications of immune type hemolytic reaction. Still, contaminated plastic sets or IV fluids can occur, and this possibility should be considered when other investigations are unproductive. Transfusion Related Acute Lung Injury (TRALI): TRALI is defined as any reaction including respiratory symptoms developing within 6 hours of a transfusion. This syndrome usually occurs following administration of plasma, but all components have been implicated. TRALI is now the most frequent cause of transfusion-related fatality. The most common presentation is respiratory distress (dyspnea, cyanosis), hypoxemia, and noncardiogenic pulmonary edema. In addition, hypotension resistant to fluid challenge and fever constitute the original pentad describing this syndrome. Respiratory and hemodynamic support are the keys to good patient management in TRALI. Respiratory regimen should be as intensive as that dictated by clinical picture. In almost all cases, oxygen supplementation is necessary. If hypoxemia is severe, intubation and mechanical ventilation will be necessary. Pressor agents are often essential in cases of sustained hypotension. Corticosteroids and diuretics have not been shown to be of clinical value. Anaphylactic and Allergic Reactions: When blood is transfused, patient receives more than 40 different plasma proteins, and sensitivity to one or a number of these can occur. The cause of these reactions is far from clear. Symptoms of allergic reaction may include: Urticaria (hives) Rash Chills and fever Allergic reactions are usually treated with antihistamines Circulatory Overload: Sudden increase in circulatory blood volume is not well tolerated by certain patients, particularly patients with cardiac or pulmonary disease, very anemic patients, or infants. Blood transfusion in these patients may cause dyspnea, coughing, pulmonary edema, or cyanosis. If these develop, STOP THE TRANSFUSION; and start treatment for circulatory overload. Units should be given at the rate of 100 to 150 ml/hour. Bacterial Reactions: Bacteria may cause transfusion reactions in 2 ways: By production of febrile reactions due to pyrogens and toxins which are breakdown products of bacteria. By causing serious, often fatal reactions, when donor blood is contaminated with large numbers of living organisms. Septic reactions are often caused by cryophilic organisms, that is to say, those capable of growing at low temperatures, eg, pseudomonads, coliforms, and achromobacters. They are usually endotoxin-producing gram-negative bacilli that can metabolize citrate as a sole source of carbon. When bacterial contamination is suspected, microscopic examination and culture of donor blood is indicated. A Gram stain and culture are automatically performed as part of a transfusion reaction investigation whenever the posttransfusion temperature rises 2.5 F. When infected blood is transfused, symptoms appear quickly (10-30 minutes) ie, chills, headache, vomiting, muscle pains, diarrhea, and high fever. Prompt, energetic treatment is required. Transmission of Disease: Transmission of HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV) from donor blood to recipient constitutes, at present time, the most common and serious problem of transfusion practice. Components such as platelets, plasma, cryoprecipitate, and fibrinogen are also responsible for HIV/HBV/HBC risk. Serum albumin, plasma protein fraction, and globulin are considered safe products, since their preparation inactivates most viruses. It is imperative that either the Blood Bank or the pathologists be contacted when a recently transfused patient shows signs of hepatitis, or any liver involvement, so that investigation can start immediately. All homologous components transfused at the MidMichigan Laboratories are tested and found to be negative for hepatitis B surface antigen (HBsAg), hepatitis B core antibodies, total (Anti-HBc), anti-hiv1/2, human T-Cell lymphotropic virus types I and II antibodies (Anti-HTLV), and anti-hiv1 antigen. Nucleic acid testing for HCV, HIV, and West Nile virus was recently instituted and NAT testing for HBV will start in the very near future. In addition, homologous units are also tested for syphilis. An algorithm for Chagas disease testing will begin in Autologous units are tested only for anti-hiv1/2.

6 What to Do if a Transfusion Reaction Occurs Symptoms: Temperature elevation of 1.8 F. Temperature should be taken before infusion, at 15 minutes and then periodically thereafter until infusion is complete. Hives, rash, itching, etc. may be signs of allergic reaction Heat along infused vein, headache, and pain in chest or lumbar region Nausea, vomiting, diarrhea Chills and/or uncontrollable shaking Shortness of breath, cyanosis, hypoxia Continuous bleeding in an anesthetized patient or unexplained increase in pulse rate With any of the above symptoms: Stop (do not necessarily disconnect) infusion. Recheck patient and donor unit identification. Record all symptoms. Call a physician to examine patient. Notify Blood Bank at Clare ( ), Gladwin ( ), Gratiot ( ext 4415) or Midland ( ), Complete Transfusion Reaction Investigation Record form, located in FormFast, and send it to the laboratory. Collect a urine specimen from patient, and send it to laboratory ASAP. If a bacterial reaction is suspected, or if transfusion is complete, send empty bag to Blood Bank. Laboratory will draw blood specimens from patient and let you know results ASAP.

2/2/2011. Blood Components and Transfusions. Why Blood Transfusion?

2/2/2011. Blood Components and Transfusions. Why Blood Transfusion? Blood Components and Transfusions Describe blood components Identify nursing responsibilities r/t blood transfusion Discuss factors r/t blood transfusion including blood typing, Rh factor, and cross matching

More information

TRANSFUSION REACTION EVALUATION

TRANSFUSION REACTION EVALUATION Lab Dept: Test Name: Transfusion Services TRANSFUSION REACTION EVALUATION General Information Lab Order Codes: Synonyms: CPT Codes: Test Includes: TRXR Transfusion Complication Workup; Hemolytic reaction

More information

Transfusion Reactions. Directed by M-azad March 2012

Transfusion Reactions. Directed by M-azad March 2012 Transfusion Reactions Directed by M-azad March 2012 Transfusion Reactions are Adverse reactions associated with the transfusion of blood and its components Transfusion reactions Non-threatening to fatal

More information

Unit 5: Blood Transfusion

Unit 5: Blood Transfusion Unit 5: Blood Transfusion Blood transfusion (BT) therapy: Involves transfusing whole blood or blood components (specific portion or fraction of blood lacking in patient). Learn the concepts behind blood

More information

Components of Blood. N26 Blood Administration 4/24/2012. Cabrillo College ADN/C. Madsen RN, MSN 1. Formed elements Cells. Plasma. What can we give?

Components of Blood. N26 Blood Administration 4/24/2012. Cabrillo College ADN/C. Madsen RN, MSN 1. Formed elements Cells. Plasma. What can we give? Components of Blood Formed elements Cells Erythrocytes (RBCs) Leukocytes (WBCs) Thrombocytes (platelets) Plasma 90% water 10% solutes Proteins, clotting factors 1 What can we give? Whole blood Packed RBC

More information

TRANSFUSION SAFETY 101 ARE YOU SMARTER THAN A BLOOD BANKER?

TRANSFUSION SAFETY 101 ARE YOU SMARTER THAN A BLOOD BANKER? TRANSFUSION SAFETY 101 ARE YOU SMARTER THAN A BLOOD BANKER? 1. Fatal blood transfusion reactions are most likely the result of: a. Circulatory overload b. ABO incompatible blood due to patient identification

More information

Blood/Blood Component Utilization and Administration Annual Compliance Education

Blood/Blood Component Utilization and Administration Annual Compliance Education Blood/Blood Component Utilization and Administration Annual Compliance Education This course contains annual compliance education necessary to meet compliance and regulatory requirements. Instructions:

More information

Mary Berg, M.D. Medical Director, Transfusion Services Associate Professor of Pathology University of Colorado Hospital

Mary Berg, M.D. Medical Director, Transfusion Services Associate Professor of Pathology University of Colorado Hospital Transfusion Reactions/Complications Mary Berg, M.D. Medical Director, Transfusion Services Associate Professor of Pathology University of Colorado Hospital Acute Transfusion Reactions Can be seen with

More information

Boot Camp Transfusion Reactions

Boot Camp Transfusion Reactions Boot Camp Transfusion Reactions Dr. Kristine Roland Regional Medical Lead for Transfusion Medicine, VCH Objectives By the end of this session, you should be able to: Describe in common language the potential

More information

MB Guideline 7. Transfusion Reaction- Identification, Management and Reporting

MB Guideline 7. Transfusion Reaction- Identification, Management and Reporting MB Guideline 7 Transfusion Reaction- Identification, Management and Reporting When any unexpected or untoward sign or symptom occurs during or shortly after the transfusion of a blood component, a transfusion

More information

Transfusion Reactions

Transfusion Reactions Transfusion Reactions From A to T Provincial Blood Coordinating Program Daphne Osborne MN PANC (C) RN We want you to know Definition Appropriate actions Classification Complete case studies Transfusion

More information

7 ADVERSE REACTIONS TO TRANSFUSION. Version July 2004, Revised 5/26/05

7 ADVERSE REACTIONS TO TRANSFUSION. Version July 2004, Revised 5/26/05 Version July 2004, Revised 5/26/05 Blood Bank Labsite Preface Table of Contents 1: General Information... 2: Providing Blood to OR... 3: Emergency Use... 4: Blood Components... 5: Utilization Review...

More information

In The Name Of GOD ADVERSE REACTIONS OF TRANSFUSION

In The Name Of GOD ADVERSE REACTIONS OF TRANSFUSION In The Name Of GOD The 7 th international and 12 th national congress on quality improvement in clinical laboratories ADVERSE REACTIONS OF TRANSFUSION By Mehdi Allahbakhshian, PhD, Hematology and Blood

More information

INVESTIGATION OF ADVERSE TRANSFUSION REACTIONS NLBCP-006. Issuing Authority

INVESTIGATION OF ADVERSE TRANSFUSION REACTIONS NLBCP-006. Issuing Authority Government of Newfoundland and Labrador Department of Health and Community Services Provincial Blood Coordinating Program INVESTIGATION OF ADVERSE TRANSFUSION REACTIONS Office of Administrative Responsibility

More information

Approach to a patient with suspected blood transfusion reaction. Raju Vaddepally, MD

Approach to a patient with suspected blood transfusion reaction. Raju Vaddepally, MD Approach to a patient with suspected blood transfusion reaction Raju Vaddepally, MD Goals Detection of Acute Transfusion Reactions (ATR) Clinical and Laboratory Evaluation of ATR Management of individual

More information

To provide guidelines for the identification, management and reporting of a suspected transfusion reaction to Transfusion Medicine Laboratory (TML).

To provide guidelines for the identification, management and reporting of a suspected transfusion reaction to Transfusion Medicine Laboratory (TML). PURPOSE To provide guidelines for the identification, management and reporting of a suspected transfusion reaction to Transfusion Medicine Laboratory (TML). SITE APPLICABILITY BC Children s Hospital and

More information

TRANSFUSION ASSOCIATED DISEASE, RECALL, OR COMPLICATION INVESTIGATION POLICY I. FATALITIES AND COMPLICATIONS ASSOCIATED WITH TRANSFUSION:

TRANSFUSION ASSOCIATED DISEASE, RECALL, OR COMPLICATION INVESTIGATION POLICY I. FATALITIES AND COMPLICATIONS ASSOCIATED WITH TRANSFUSION: I. FATALITIES AND COMPLICATIONS ASSOCIATED WITH TRANSFUSION: A. TRANSFUSION RELATED FATALITY: FDA and MEDIC must be notified immediately, and subsequently in writing, when a possible transfusion related

More information

COMPLICATIONS OF BLOOD TRANSFUSIONS. :Prepared by Dr. Nawal Mogales & Dr. Mohammed Aqlan

COMPLICATIONS OF BLOOD TRANSFUSIONS. :Prepared by Dr. Nawal Mogales & Dr. Mohammed Aqlan COMPLICATIONS OF BLOOD TRANSFUSIONS :Prepared by Dr. Nawal Mogales & Dr. Mohammed Aqlan COMPLICATIONS OF TRANSFUSIONS Transfusion reaction may result from either : A. Immune transfusion reaction. B. Non

More information

TRANSFUSION REACTIONS

TRANSFUSION REACTIONS 14 TRANSFUSION REACTIONS 14.1 INTRODUCTION Transfusion of blood and blood products are reported to cause reactions during or after procedure specially in patients who receive multiple transfusions. These

More information

INVESTIGATION OF ADVERSE TRANSFUSION REACTIONS TABLE OF RECOMMENDED TESTS. Type of Reaction Presentation Recommended Tests Follow-up Tests

INVESTIGATION OF ADVERSE TRANSFUSION REACTIONS TABLE OF RECOMMENDED TESTS. Type of Reaction Presentation Recommended Tests Follow-up Tests Minor Allergic (Urticarial) Urticaria, pruritis, flushing, rash If skin reaction only and mild hives/ rash

More information

A Patient s Guide to Blood Components and Products

A Patient s Guide to Blood Components and Products 2014 A Patient s Guide to Blood Components and Products Contents What is a blood transfusion?... 1 Informed consent... 1 Frequently asked questions about blood transfusions... 2 What can I expect during

More information

Investigation of Transfusion Complications

Investigation of Transfusion Complications 1.0 Principle To investigate suspected transfusion complications. 2.0 Scope and Related Policies 2.1. There shall be policies and procedures for documentation, reporting, evaluation and follow-up of all

More information

CSL Behring LLC Albuminar -25 US Package Insert Albumin (Human) USP, 25% Revised: 01/2008 Page 1

CSL Behring LLC Albuminar -25 US Package Insert Albumin (Human) USP, 25% Revised: 01/2008 Page 1 Page 1 CSL Behring Albuminar -25 Albumin (Human) USP, 25% R x only DESCRIPTION Albuminar -25, Albumin (Human) 25%, is a sterile aqueous solution of albumin obtained from large pools of adult human venous

More information

A Transfusion Reaction What Do I Do Now? Judith A. Sullivan, MS, MT(ASCP)SBB, CQA(ASQ) ASCLS Region III Triennial Meeting Birmingham AL

A Transfusion Reaction What Do I Do Now? Judith A. Sullivan, MS, MT(ASCP)SBB, CQA(ASQ) ASCLS Region III Triennial Meeting Birmingham AL A Transfusion Reaction What Do I Do Now? Judith A. Sullivan, MS, MT(ASCP)SBB, CQA(ASQ) ASCLS Region III Triennial Meeting Birmingham AL This promotional educational activity is brought to you by Ortho

More information

Blood Transfusion Reactions

Blood Transfusion Reactions Blood Transfusion Reactions Introduction Many individuals require blood components and blood products. As per the BC Transfusion Medicine Advisory Group (BCTMAG), a blood component is at therapeutic component

More information

Chapter 8 ADMINISTRATION OF BLOOD COMPONENTS

Chapter 8 ADMINISTRATION OF BLOOD COMPONENTS Chapter 8 ADMINISTRATION OF BLOOD COMPONENTS PRACTICE POINTS Give the right blood product to the right patient at the right time. Failure to correctly check the patient or the pack can be fatal. At the

More information

Blood & Blood Product Administration

Blood & Blood Product Administration Approved by: Blood & Blood Product Administration Addendum to: Corporate Policy VII-B-397 Transfusion of Blood Components and Products- Pediatric/Neonate Gail Cameron Senior Director Operations, Maternal,

More information

Non-Infectious Transfusion Reactions

Non-Infectious Transfusion Reactions Non-Infectious Transfusion Reactions Transfusion Reactions ANY unfavorable consequence is considered a transfusion reaction of blood TX The risks of transfusion must be weighed against the benefits Transfusion

More information

CrackCast Episode 7 Blood and Blood Components

CrackCast Episode 7 Blood and Blood Components CrackCast Episode 7 Blood and Blood Components Episode Overview: 1) Describe the 3 categories of blood antigens 2) Who is the universal donor and why? 3) Define massive transfusion 4) List 5 physiologic

More information

Transfusion 2004: Current Practice Standards. Kay Elliott, MT (ASCP) SBB SWMC Transfusion Service

Transfusion 2004: Current Practice Standards. Kay Elliott, MT (ASCP) SBB SWMC Transfusion Service Transfusion 2004: Current Practice Standards Kay Elliott, MT (ASCP) SBB SWMC Transfusion Service Massive Transfusion Protocol (MTP) When should it be activated? Massive bleeding i.e. loss of one blood

More information

Olive J Sturtevant, MHP, MT(ASCP)SBB/SLS, CQA Director, Cellular Therapy Quality Assurance Dana Farber Cancer Institute

Olive J Sturtevant, MHP, MT(ASCP)SBB/SLS, CQA Director, Cellular Therapy Quality Assurance Dana Farber Cancer Institute Adverse Events associated with Cell Therapy Products Olive J Sturtevant, MHP, MT(ASCP)SBB/SLS, CQA Director, Cellular Therapy Quality Assurance Dana Farber Cancer Institute 2 Objectives Review the types

More information

A transfusion reaction is any adverse effect of transfusion therapy which occurs during or after administration of a blood component

A transfusion reaction is any adverse effect of transfusion therapy which occurs during or after administration of a blood component Brenda C. Barnes, Ph.D., MT(ASCP)SBB 1/2015 1 A transfusion reaction is any adverse effect of transfusion therapy which occurs during or after administration of a blood component Transfusion of any blood

More information

Blood Administration and Transfusion Reactions. This course has been awarded two (2.0) contact hours.

Blood Administration and Transfusion Reactions. This course has been awarded two (2.0) contact hours. Blood Administration and Transfusion Reactions This course has been awarded two (2.0) contact hours. Copyright 2018 by RN.com. All Rights Reserved. Reproduction and distribution of these materials are

More information

Immunological transfusion reactions

Immunological transfusion reactions Immunological transfusion reactions Immunological transfusion reactions can be hemolytic or non-hemolytic in nature. Both types can be separated into acute (those occurring immediately after transfusion)

More information

Transfusion reactions illustrated

Transfusion reactions illustrated Transfusion reactions illustrated Chapter 1 Transfusion practice 1 Procedure of transfusion practice In general, transfusion-associated incidents occur due to multiple errors, most of which occur in the

More information

For more information about how to cite these materials visit

For more information about how to cite these materials visit Author(s): Robertson Davenport, M.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution Noncommercial Share Alike 3.0 License: http://creativecommons.org/licenses/by-nc-sa/3.0/

More information

Blood Transfusion. What is blood transfusion? What are blood banks? When is a blood transfusion needed? Who can donate blood?

Blood Transfusion. What is blood transfusion? What are blood banks? When is a blood transfusion needed? Who can donate blood? What is blood transfusion? A blood transfusion is a safe, common procedure in which blood is given through an intravenous (IV) line in one of the blood vessels. A blood transfusion usually takes two to

More information

COMPANY CORE PACKAGE INSERT CCPI (PI/CORE/ENGLISH)

COMPANY CORE PACKAGE INSERT CCPI (PI/CORE/ENGLISH) COMPANY CORE PACKAGE INSERT CCPI (PI/CORE/ENGLISH) HUMAN ALBUMIN 20 % BEHRING Rev.: 05-MAR-2008 / PEI approval 26.02.08 Supersedes previous versions Rev.: 28-NOV-2007 / Adaptation to Core SPC Rev.: 02-JAN-2007

More information

FLUID MANAGEMENT AND BLOOD COMPONENT THERAPY

FLUID MANAGEMENT AND BLOOD COMPONENT THERAPY Manual: Section: Protocol #: Approval Date: Effective Date: Revision Due Date: 10/2019 LifeLine Patient Care Protocols Adult/Pediatrics AP1-011 10/2018 10/2018 FLUID MANAGEMENT AND BLOOD COMPONENT THERAPY

More information

Blood is serious business

Blood is serious business Transfusion at RCH BLOOD TRANSFUSION Anthea Greenway Dept of Clinical Haematology >10000 fresh blood products per year Supports craniofacial and cardiac surgery Support bone marrow, liver transplant and

More information

TRANSFUSION OF BLOOD COMPONENTS ADMINISTRATION. All blood components are administered according to BOP DHB Policy and NZBS Guidelines.

TRANSFUSION OF BLOOD COMPONENTS ADMINISTRATION. All blood components are administered according to BOP DHB Policy and NZBS Guidelines. STANDARDS All blood components are administered according to BOP DHB Policy and NZBS Guidelines. EQUIPMENT IV administration set with 260 micron filter either integrated blood filter; or add on blood filter

More information

Transfusion Therapy & Safety. Mary Grabowski, RN, BSN, BSIA Transfusion Safety Officer PSONEC Fundamentals September, 2015

Transfusion Therapy & Safety. Mary Grabowski, RN, BSN, BSIA Transfusion Safety Officer PSONEC Fundamentals September, 2015 Transfusion Therapy & Safety Mary Grabowski, RN, BSN, BSIA Transfusion Safety Officer PSONEC Fundamentals September, 2015 Topics Blood Components Special Processing/Attributes Irradiation Leukoreduction

More information

TRANSFUSION REACTION AMONG THE BLOOD RECIPIENT - A STUDY OF 120 CASES

TRANSFUSION REACTION AMONG THE BLOOD RECIPIENT - A STUDY OF 120 CASES TRANSFUSION REACTION AMONG THE BLOOD RECIPIENT - A STUDY OF 120 CASES Chowdhury FS 1, Biswas J 2, Siddiqui MAE 3, Hoque MM 4, Adnan SK 5 Abstract: Context: Blood transfusion is a life saving procedure.

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. octaplaslg mg/ml solution for infusion Human plasma proteins

PACKAGE LEAFLET: INFORMATION FOR THE USER. octaplaslg mg/ml solution for infusion Human plasma proteins PACKAGE LEAFLET: INFORMATION FOR THE USER octaplaslg 45-70 mg/ml solution for infusion Human plasma proteins Read all of this leaflet carefully before you start using this medicine. - Keep this leaflet.

More information

Blood Components & Indications for Transfusion. Neda Kalhor

Blood Components & Indications for Transfusion. Neda Kalhor Blood Components & Indications for Transfusion Neda Kalhor Blood products Cellular Components: Red blood cells - Leukocyte-reduced RBCs - Washed RBCs - Irradiated RBCs Platelets - Random-donor platelets

More information

REPORT OF TRANSFUSION ADVERSE REACTION TO BLOOD CENTERS

REPORT OF TRANSFUSION ADVERSE REACTION TO BLOOD CENTERS REPORT OF TRANSFUSION ADVERSE REACTION TO BLOOD CENTERS INSTRUCTIONS: Send the form to ALL blood centers that provided blood components to this patient. Timely reporting is important, so that, if appropriate,

More information

SUMMARY OF PRODUCT CHARACTERISTICS. Flexbumin 200 g/l is a solution containing 200 g/l (20%) of total protein of which at least 95% is human albumin.

SUMMARY OF PRODUCT CHARACTERISTICS. Flexbumin 200 g/l is a solution containing 200 g/l (20%) of total protein of which at least 95% is human albumin. SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Flexbumin 200g/l solution for infusion 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Flexbumin 200 g/l is a solution containing 200 g/l

More information

WRHA Blood Conservation Service WRHA Transfusion Practice Committee. TEAM TRANSFUSION Differential Diagnosis of Adverse Events

WRHA Blood Conservation Service WRHA Transfusion Practice Committee. TEAM TRANSFUSION Differential Diagnosis of Adverse Events WRHA Blood Conservation Service WRHA Transfusion Practice Committee TEAM TRANSFUSION Differential Diagnosis of Adverse Events MANITOBA ADVERSE EVENT REPORTING SYSTEM DATA FLOW REACTION Physician orders

More information

Transfusion Medicine Potpourri. BUMC - Phoenix Internal Medicine Residents September 29, 2015

Transfusion Medicine Potpourri. BUMC - Phoenix Internal Medicine Residents September 29, 2015 Transfusion Medicine Potpourri BUMC - Phoenix Internal Medicine Residents September 29, 2015 Clinical case A 24 year old female with sickle cell anemia has just moved to the area and presents as a new

More information

Patient Blood Management. Marisa B. Marques, MD UAB Department of Pathology November 17, 2016

Patient Blood Management. Marisa B. Marques, MD UAB Department of Pathology November 17, 2016 Patient Blood Management Marisa B. Marques, MD UAB Department of Pathology November 17, 2016 Learning Objectives Upon completion of the session, the participant will: 1) Differentiate between the various

More information

Transfusion Reactions:

Transfusion Reactions: Transfusion Reactions: Melissa R. George, D.O., F.C.A.P. Medical Director, Transfusion Medicine & Apheresis Penn State Milton S. Hershey Medical Center Office: HG069, Phone: 717-531-4627 E-mail: mgeorge5@hmc.psu.edu

More information

Approved: Paula Webb, DNP, RN, NEA-BC Vice President, Nursing/CNO Review: Initial/Date

Approved: Paula Webb, DNP, RN, NEA-BC Vice President, Nursing/CNO Review: Initial/Date Subject: BLOOD PRODUCTS: A. Consent B. Emergency Order/Consent C. Ordering D. Specimen E. Patient ID F. Distribution and Administration G. Transfusion Reaction H. Information Sheet for Patients Being Discharged

More information

Blood Transfusion Orientation & Information 2010

Blood Transfusion Orientation & Information 2010 Blood Transfusion Orientation & Information 2010 *if you are able to get online for this training: http://www.nhlbi.nih.gov/health/dci/diseases/bt/bt_whatis.html and you can read all information included

More information

TITLE CLIN_092 ADMINISTRATION OF BLOOD AND BLOOD COMPONENTS

TITLE CLIN_092 ADMINISTRATION OF BLOOD AND BLOOD COMPONENTS Policies and procedures are guidelines and are not a substitute for the exercise of individual judgment. If you are reading a printed copy of this policy, make sure it is the most current by checking the

More information

Transfusion Medicine Kris0ne Kra1s, M.D.

Transfusion Medicine Kris0ne Kra1s, M.D. Transfusion Medicine Kris0ne Kra1s, M.D. Transfusion Medicine Outline Blood groups Introduc0on ABO system Rh system Other systems Blood transfusion Blood products Indica0ons Tes0ng Dangers Transfusion

More information

Have you ever managed patients who have experienced an adverse reaction to transfusion?

Have you ever managed patients who have experienced an adverse reaction to transfusion? Have you ever managed patients who have experienced an adverse reaction to transfusion? A. Yes, often B. Yes, occasionally C. No A. 1 in 30 units? B. 1 in 100? C. 1 in 1000? D. 1 in 10,000? SHOT collects

More information

BLOOD TRANSFUSIONS. Answers. To Your. Questions

BLOOD TRANSFUSIONS. Answers. To Your. Questions BLOOD TRANSFUSIONS Answers To Your Questions Answers to Your Questions This brochure is intended for people who may need a blood or blood product transfusion and for those who regularly receive transfusions.

More information

Answers. To Your. Questions

Answers. To Your. Questions Blood Transfusions Answers To Your Questions Answers to Your Questions This brochure is intended for people who may need a blood or blood product transfusion and for those who regularly receive transfusions.

More information

In the United States, transfusion reactions are reported to occur. Global Prevalence. Evolution of Transfusion Practices

In the United States, transfusion reactions are reported to occur. Global Prevalence. Evolution of Transfusion Practices Evolution of Transfusion Practices TRALI, TACO, and other Transfusion Complications Michael Rieker, DNP, CRNA Wake Forest Baptist Medical Center 1665 - The first Blood transfusions of record take place.

More information

Blood Products & Transfusion. Karim Rafaat, M.D.

Blood Products & Transfusion. Karim Rafaat, M.D. Blood Products & Transfusion Karim Rafaat, M.D. Compatibility Testing Compatibility testing involves three separate procedures involving both donor and recipient blood. 1. ABO & Rh blood type identification

More information

Transfusion Service Guidelines

Transfusion Service Guidelines Transfusion Service Guidelines Inland Northwest Blood Center 210 W. Cataldo Avenue Spokane, WA 99201 TS 001 (Rev. 6) Page 1 of 22 Overview In order to provide the safest blood components for patients,

More information

Blood transfusion. Dr. J. Potgieter Dept. of Haematology NHLS - TAD

Blood transfusion. Dr. J. Potgieter Dept. of Haematology NHLS - TAD Blood transfusion Dr. J. Potgieter Dept. of Haematology NHLS - TAD General Blood is collected from volunteer donors >90% is separated into individual components and plasma Donors should be: healthy, have

More information

Human Albumin 200 g/l Baxter is a solution containing 200 g/l of total protein of which at least 95% is human albumin.

Human Albumin 200 g/l Baxter is a solution containing 200 g/l of total protein of which at least 95% is human albumin. 1. NAME OF THE MEDICINAL PRODUCT Human Albumin 200 g/l Baxter Solution for Infusion 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Human Albumin 200 g/l Baxter is a solution containing 200 g/l of total protein

More information

BLOOD TRANSFUSIONS. Answers. To Your. Questions

BLOOD TRANSFUSIONS. Answers. To Your. Questions BLOOD TRANSFUSIONS Answers To Your Questions Answers to Your Questions This brochure is intended for people who may need a blood or blood product transfusion and for those who regularly receive transfusions.

More information

Plasma exchange. Information for patients Sheffield Kidney Institute (Renal Unit)

Plasma exchange. Information for patients Sheffield Kidney Institute (Renal Unit) Plasma exchange Information for patients Sheffield Kidney Institute (Renal Unit) Plasma exchange This leaflet explains about plasma exchange; the benefits, risks, alternatives and what you can expect when

More information

Immunohematology (Introduction)

Immunohematology (Introduction) Modified from Serotonin version Immunohematology (Introduction) References: -Blood Groups and Red Cell Antigens (Laura Dean) -Cellular and molecular immunology, 8 th edition Introduction to replace blood

More information

Information for professionals for Cytotect CP Biotest: Biotest (Switzerland) AG Complete information for professionals DDD Print

Information for professionals for Cytotect CP Biotest: Biotest (Switzerland) AG Complete information for professionals DDD Print Information for professionals for Cytotect CP Biotest: Biotest (Switzerland) AG Complete information for professionals DDD Print Composition 1 ml solution contains: Active ingredients:. plasma proteins

More information

3. PHARMACEUTICAL FORM Solution for infusion. A clear, slightly viscous liquid; it is almost colourless, yellow, amber or green.

3. PHARMACEUTICAL FORM Solution for infusion. A clear, slightly viscous liquid; it is almost colourless, yellow, amber or green. 1. NAME OF THE MEDICINAL PRODUCT Albutein 250 g/l, solution for infusion. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Human albumin Albutein 250 g/l is a solution containing 250 g/l of total protein of

More information

Blood Transfusion. Dr Will Dooley

Blood Transfusion. Dr Will Dooley Blood Transfusion Dr Will Dooley Plan Cases OSCE practice scenario Blood groups Monitoring / Reactions Miss Irene Bleede, 23yo Asymptomatic, healthy woman with menorrhagia Hb 78 g/l, MCV 73fl Would you

More information

Blood Transfusion. Dr William Dooley

Blood Transfusion. Dr William Dooley Blood Transfusion Dr William Dooley Plan Cases Blood groups / Indications Procedure Monitoring / Reactions Cases For following cases: - Would you give them a blood transfusion? - How many units you would

More information

Crossmatching and Issuing Blood Components; Indications and Effects.

Crossmatching and Issuing Blood Components; Indications and Effects. Crossmatching and Issuing Blood Components; Indications and Effects. Alison Muir Blood Transfusion, Blood Sciences, Newcastle Trust Topics Covered Taking the blood sample ABO Group Antibody Screening Compatibility

More information

What You Need to Know About Blood Transfusion. Elianna Saidenberg May 2014

What You Need to Know About Blood Transfusion. Elianna Saidenberg May 2014 What You Need to Know About Blood Transfusion Elianna Saidenberg May 2014 Objectives Why your doctor might order transfusion therapy Where does the blood come from The beginning of your transfusion Consent

More information

SUMMARY OF PRODUCT CHARACTERISTICS. Albuman 40 g/l is a solution containing 40 g/l (4%) of total protein of which at least 95% is human albumin.

SUMMARY OF PRODUCT CHARACTERISTICS. Albuman 40 g/l is a solution containing 40 g/l (4%) of total protein of which at least 95% is human albumin. SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Albuman 40 g/l solution for infusion 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Albuman 40 g/l is a solution containing 40 g/l (4%)

More information

2 QUALITATIVE AND QUANTITATIVE COMPOSITION

2 QUALITATIVE AND QUANTITATIVE COMPOSITION SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Albunorm 5%, 50 g/l, solution for infusion 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Albunorm 5% is a solution containing 50 g/l of total

More information

For platelet control as individual as you

For platelet control as individual as you For platelet control as individual as you Explore the possibilities of Immune Thrombocytopenic Purpura (ITP) treatment. Important Risk Information WARNING: INTRAVASCULAR HEMOLYSIS (IVH) Intravascular hemolysis

More information

Guidelines for Use of Canine Blood Components

Guidelines for Use of Canine Blood Components Guidelines for Use of Canine Blood Components Cryoprecipitate This product is prepared by a controlled thaw of fresh frozen plasma, resulting in a concentration of Factor VIII, Factor XIII, vwf and some

More information

GUIDELINES FOR WEIGHT-BASED DOSING AND INFUSION

GUIDELINES FOR WEIGHT-BASED DOSING AND INFUSION GUIDELINES FOR WEIGHT-BASED DOSING AND INFUSION Includes Example dose calculation wheel Preparation and administration information for healthcare professionals Please see enclosed full Prescribing Information,

More information

Learning Objectives: At the end of this exercise, the student will be able to:

Learning Objectives: At the end of this exercise, the student will be able to: Applications in Transfusion Medicine- A CBL Exercise- Student Guide 1 Title: Applications in Transfusion Medicine A CBL Exercise Purpose: At the conclusion of this exercise, students will be able to apply

More information

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT 2 QUALITATIVE AND QUANTITATIVE COMPOSITION

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT 2 QUALITATIVE AND QUANTITATIVE COMPOSITION SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Albunorm 20%, 200 g/l, solution for infusion 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Albunorm 20% is a solution containing 200 g/l

More information

UKGS TRANSFUSION SERVICE PRODUCTS AND AVAILABILITY

UKGS TRANSFUSION SERVICE PRODUCTS AND AVAILABILITY Lexington, KY Page 1 of 13 Affected Sites: Enterprise Chandler X Good Samaritan I. PRINCIPLE: The UK Good Samaritan Hospital is dedicated to serve the patients with safe, high quality blood products and

More information

Table 1: In vitro reduction factor during Albumin (Human) 25% manufacturing

Table 1: In vitro reduction factor during Albumin (Human) 25% manufacturing Albumin (Human) 25% U.S. License No. 1646 Rx only DESCRIPTION Albumin (Human) 25% is a sterile, liquid preparation of albumin derived from large pools of human plasma. All units of human plasma used in

More information

Blood transfusion. General surgery department of SGMU Lecturer ass. Khilgiyaev R.H.

Blood transfusion. General surgery department of SGMU Lecturer ass. Khilgiyaev R.H. Blood transfusion General surgery department of SGMU Sources of blood Donors Own blood of patient (autoreinfusion): autoreinfusion of blood from cavities (haemotorax, haemoperitoneum) in case of acute

More information

Red blood cell transfusion

Red blood cell transfusion Red blood cell transfusion This leaflet explains more about red blood cell transfusion, including the benefits, risks and any alternatives and what you can expect when you come to hospital. If you have

More information

Definitions of Current SHOT Categories & What to Report

Definitions of Current SHOT Categories & What to Report Definitions of Current SHOT Categories & What to Report Revised March 2011 1 ADVERSE EVENTS TERM DEFINITION WHAT TO REPORT IBCT - Wrong Blood Transfused (Incorrect Blood Component Transfused) Where a patient

More information

Blood Transfusion. OM Nursing Academy Anil Kantiwal Gudha. Blood Transfusion is the Replacement of Blood or its components.

Blood Transfusion. OM Nursing Academy Anil Kantiwal Gudha. Blood Transfusion is the Replacement of Blood or its components. Blood Transfusion OM Nursing Academy Anil Kantiwal Gudha Introduction :- Blood Transfusion is the Replacement of Blood or its components. Or Blood Transfusion is a life saving Procedure to place the Blood

More information

Module 11 FINAL EXAMINATION

Module 11 FINAL EXAMINATION Module 11 FINAL EXAMINATION MULTIPLE CHOICE Select the one best answer 1. The type of IV fluid appropriate for the patient with ketosis is a. electrolyte solution b. nutrient solution c. blood volume expander

More information

Plasma-derived products Information for patients

Plasma-derived products Information for patients Plasma-derived products Information for patients page 2 You have been given this leaflet as your doctor has advised you that you may require plasma-derived products as a treatment for your bleeding disorder.

More information

Bassett Medical Center The Mary Imogene Bassett Hospital Clinical Laboratory Blood Bank Title: MTP 2016 Revision: 2.00 Created By: Admin, The Last

Bassett Medical Center The Mary Imogene Bassett Hospital Clinical Laboratory Blood Bank Title: MTP 2016 Revision: 2.00 Created By: Admin, The Last Bassett Medical Center The Mary Imogene Bassett Hospital Clinical Laboratory Blood Bank Title: MTP 2016 Revision: 2.00 Created By: Admin, The Last Approved Time: 7/22/2016 12:44:54 PM Massive Transfusion

More information

X-Plain Blood Transfusion Reference Summary

X-Plain Blood Transfusion Reference Summary X-Plain Blood Transfusion Reference Summary Introduction Blood transfusions are very common. Each year, almost 5 million Americans need a blood transfusion. Blood transfusions are given to replace blood

More information

EDUCATIONAL COMMENTARY TRANSFUSION-RELATED ACUTE LUNG INJURY

EDUCATIONAL COMMENTARY TRANSFUSION-RELATED ACUTE LUNG INJURY EDUCATIONAL COMMENTARY TRANSFUSION-RELATED ACUTE LUNG INJURY Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE

More information

Consent Laboratory Transfuse RBC

Consent Laboratory  Transfuse RBC Peds Blood Product Infusion Order Set (386) [386] Blood product review will be performed unless exclusion criteria met. MD: Please note if transfusion giv en outside of parameter, please justify use in

More information

Immunohaematology: a branch of immunology that deals with the immunologic properties of blood.

Immunohaematology: a branch of immunology that deals with the immunologic properties of blood. 1 Immunohaematology: a branch of immunology that deals with the immunologic properties of blood. The red blood cells have on their surface hundreds of antigens and according to the antigen on their surface

More information

Haemovigilance: Acute transfusion reactions. Paula Bolton-Maggs Medical Director Serious Hazards of Transfusion

Haemovigilance: Acute transfusion reactions. Paula Bolton-Maggs Medical Director Serious Hazards of Transfusion Haemovigilance: Acute transfusion reactions Paula Bolton-Maggs Medical Director Serious Hazards of Transfusion SHOT Cumulative data: 18 years n=14822 Deaths related to transfusion reported in 2015 Total

More information

A Patient s guide to. Blood Transfusions and Human Tissue Transplant

A Patient s guide to. Blood Transfusions and Human Tissue Transplant A Patient s guide to Blood Transfusions and Human Tissue Transplant Why might I need a blood transfusion? Blood transfusions are given to replace blood lost in surgery or to treat anaemia (lack of red

More information

What s in the Massive Transfusion Protocol (MTP) Package?

What s in the Massive Transfusion Protocol (MTP) Package? What s in the Massive Transfusion Protocol (MTP) Package? The Massive Transfusion Protocol Package is a set of documents intended to improve the coordination of a Massive Transfusion Protocol. The kit

More information

(human albumin solution) POM SUMMARY OF PRODUCT CHARACTERISTICS

(human albumin solution) POM SUMMARY OF PRODUCT CHARACTERISTICS albunorm TM 20% (human albumin solution) POM SUMMARY OF PRODUCT CHARACTERISTICS UK IRELAND and Ireland Octapharma Limited The Zenith Building, 26 Spring Gardens Manchester M2 1AB United Kingdom 1. Name

More information

(human albumin solution) POM SUMMARY OF PRODUCT CHARACTERISTICS

(human albumin solution) POM SUMMARY OF PRODUCT CHARACTERISTICS albunorm TM 5% (human albumin solution) POM SUMMARY OF PRODUCT CHARACTERISTICS UK IRELAND and Ireland Octapharma Limited The Zenith Building, 26 Spring Gardens Manchester M2 1AB United Kingdom 1. Name

More information

Blood Administration and Transfusion Reactions

Blood Administration and Transfusion Reactions Blood Administration and Transfusion Reactions This course has been awarded two (2.0) contact hours. This course expires on November 30, 2018 Copyright 2005 by RN.com. All Rights Reserved. Reproduction

More information

The establishment of well-organized, nationally-coordinated blood transfusion services with quality systems in all areas

The establishment of well-organized, nationally-coordinated blood transfusion services with quality systems in all areas Blood Safety Global Database on Blood Safety (GDBS) 2013 The World Health Organization (WHO) programme on Blood Transfusion Safety would appreciate your kind cooperation in completing this data collection

More information

ADULT TRANSFUSION GUIDELINES ORDERED COMPONENT

ADULT TRANSFUSION GUIDELINES ORDERED COMPONENT ADULT TRANSFUSIN GUIDELINES RDERED Packed red cells (RBCs) RBCs, WBCs, platelets & plasma (minimal) Increase red cell mass and oxygen carrying capacity; generally indicated when Hgb is 7 gm or Hct 21 unless

More information